Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3088081 | 0.97 | CYP1A2 (0.50) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL4406066 | 0.91 | CYP1A2 (0.46) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| Cyanide SCHEMBL21808145 | 0.91 | CYP1A1 (0.52) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL1127627 | 0.84 | FNTA (0.54) | CYP1A2IDO1CA1CA2CA9 | |
| Bisbenzyldiselenide SCHEMBL441260 | 0.80 | CYP1A1 (0.52) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL28859310 | 0.79 | CYP1A2 (0.41) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL28452710 | 0.79 | TP53 (0.46) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL9279484 | 0.78 | — | — | |
| Bisbenzyldiselenide SCHEMBL29169728 | 0.78 | CYP1A1 (0.56) | CYP1A2CYP1A1CYP1B1CALM1TSHR | |
| SCHEMBL28439038 | 0.75 | TP53 (0.42) | CYP1A2CYP1A1CYP1B1TP53HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920916-B | Continuous synthesis method of poly (butylene succinate) | 上海师范大学 | 2023-11-28 | — | — | CN | claimed |
| CN-113980252-B | Continuous production method of modified poly (butylene succinate) | 上海师范大学 | 2023-09-01 | — | — | CN | claimed |
| CN-112501583-B | Preparation method of transition metal diselenide film | 北京大学深圳研究生院 | 2023-01-24 | — | — | CN | claimed |
| CN-113980252-A | Continuous production method of modified poly (butylene succinate) | 上海师范大学 | 2022-01-28 | — | — | CN | claimed |
| CN-112501583-A | Preparation method of transition metal diselenide film | 北京大学深圳研究生院 | 2021-03-16 | — | — | CN | claimed |
| CN-104477856-B | A kind of synthetic method of cadmium telluride quantum dot and the synthetic method of II type cadmium telluride core-shell quanta dots | CHAO HU UNIVERSITY (CN) | 2016-03-09 | — | — | CN | claimed |
| CN-103911155-B | A kind of core-shell quanta dots of red-emitting and synthetic method thereof | CHAO HU UNIVERSITY (CN) | 2016-01-20 | — | — | CN | claimed |
| CN-104477856-A | Synthesis method of cadmium telluride quantum dots and synthesis method of Type II cadmium telluride core-shell quantum dots | CHAO HU UNIVERSITY | 2015-04-01 | — | — | CN | claimed |
| CN-103911155-A | Red light-emitting core-shell quantum dot and synthetic method thereof | CHAO HU UNIVERSITY | 2014-07-09 | — | — | CN | claimed |
| US-6482311-B1 | Methods for suppression of filamentous coke formation | TDA RESEARCH, INC. | 2002-11-19 | — | — | US | claimed |
| US-20020128161-A1 | Materials and methods for suppression of filamentous coke formation | AIR FORCE, UNITED STATES | 2002-09-12 | — | — | US | claimed |
| US-20260132541-A1 | SYNTHESIS OF MONOLAYER TRANSITION METAL DICHALCOGENIDES BY ELECTROSTATIC SELF-ASSEMBLY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2026-05-14 | — | — | US | disclosed |
| US-12379525-B2 | Plastic lens | DAICEL CORPORATION (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250242575-A1 | HARDCOAT-LESS FILM, LAMINATE, MULTILAYER LAMINATE, AND DISPLAY DEVICE | DAICEL CORPORATION (JP) | 2025-07-31 | — | — | US | disclosed |
| US-20250248279-A1 | TRANSPARENT LAMINATE, IMAGE DISPLAY DEVICE, AND FLEXIBLE DEVICE | DAICEL CORPORATION (JP) | 2025-07-31 | — | — | US | disclosed |
| US-4013528-A | SELENOUREA COMPOUND DECOMPOSED TO SELENIUM | XEROX CORPORATION (US) | 1977-03-22 | — | — | US | disclosed |
| US-4007101-A | DECOMPOSITION OF ORGANO-SELENIUM COMPOUNDS | XEROX CORPORATION (US) | 1977-02-08 | — | — | US | disclosed |
| US-4007100-A | Process for preparation of solid phase dispersion of photoconductive materials | XEROX CORPORATION (US) | 1977-02-08 | — | — | US | disclosed |
| US-3994791-A | FORMING SELENIUM FROM ORGANO-SELENIUM COMPOUNDS | XEROX CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
| US-3967964-A | Photosensitive film comprising an organopolyselenide and an organomercury compound | XEROX CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132541-A1 | SYNTHESIS OF MONOLAYER TRANSITION METAL DICHALCOGENIDES BY ELECTROSTATIC SELF-ASSEMBLY | DCX, DSG1, MEF2D | CYP1A2 2428/4885CYP1A1 3215/4885CYP1B1 3203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.